HCG completes sale of BACC Health Care subsidiary to Inviga Healthcare Fund

Strategic Transactions View source PDF Explain this filing

HCG · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.8%Reaction day

₹594.30

prior close

₹595.65

announcement price

After-mkt

timing

Nifty Microcap 250market+1.0%+4.7% vs market

Hospital peers, median of 24sector+0.9%+4.9% vs sector

On the reaction day the stock moved 4.7 pts more than Nifty Microcap 250 and 4.9 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.8

10m

+1.0

15m

+1.2

30m

+1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.8+1.0+4.7+0.9+4.9

Next day

+6.8+1.2+5.6+1.2+5.6

+8.9+2.1+6.9+1.3+7.6

+10.3+1.7+8.6+1.4+8.9

+9.7+1.9+7.7+0.7+9.0

+9.5+1.2+8.3+0.2+9.4

+10.2+1.1+9.1+0.6+9.6

15d

+11.5+1.6+9.9+1.2+10.3

+13.4+0.1+13.3-1.0+14.4

+23.7+6.6+17.0+1.1+22.6

+12.4+5.5+6.9-5.3+17.6

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 24Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

HCG has completed sale of its entire stake (99.999%, or 93,577 of 93,578 shares) in subsidiary BACC Health Care Private Limited to Inviga Healthcare Fund I on June 29, 2026. Total deal value is Rs 37.64 crores. Initial consideration of Rs 28.23 crores has been received. Balance of about Rs 9.41 crores is deferred and payable within 18 months of the May 19, 2026 signing, and is time-deferred only, not conditional.

Likely market impact

Brings in Rs 28.23 crores cash now and Rs 9.41 crores later. Exits the BACC subsidiary, removing its revenue, costs, and any related debt from HCG books.